Advertisement

Patient-tailored ovarian stimulation for in vitro fertilization

  • Bart C.J.M. Fauser
    Correspondence
    Reprint requests: Bart C.J.M. Fauser, M.D., Ph.D., Department of Reproductive Medicine and Gynecology, University Medical Center, Utrecht 3584 CX, The Netherlands.
    Affiliations
    Department of Reproductive Medicine and Gynecology, University Medical Center, Utrecht, the Netherlands
    Search for articles by this author
      At present, much attention in medicine is being directed toward individualized or patient-tailored care with the use of novel tools such as biomarkers or genomics. Research tools different from randomized controlled trials, focusing on the heterogeneity of patients rather than the intervention per se, are required to develop this concept further. In infertility care, few examples of individualized approaches with the use of multivariate prediction models can be found, such as the prediction of spontaneous conception chances in infertile patients or regarding the medical treatment of anovulatory infertility. Few prospective studies have been published in recent years concerning individualized dosing based on response prediction for ovarian stimulation in IVF. Potentially much may be gained by such methods because at present ovarian response to stimulation varies greatly, with distinct implications for both efficacy and safety of IVF treatment.

      Key Words

      To read this article in full you will need to make a payment

      References

        • Mega J.L.
        • Sabatine M.S.
        • Antman E.M.
        Population and personalized medicine in the modern era.
        JAMA. 2014; 312: 1969-1970
        • Bothwell L.E.
        • Greene J.A.
        • Podolsky S.H.
        • Jones D.S.
        Assessing the gold standard—lessons from the history of RCTs.
        N Engl J Med. 2016; 374: 2175-2181
        • Legro R.S.
        • Brzyski R.G.
        • Diamond M.P.
        • Coutifaris C.
        • Schlaff W.D.
        • Casson P.
        • et al.
        • NICHD Reproductive Medicine Network
        Letrozole versus clomiphene for infertility in the polycystic ovary syndrome.
        N Engl J Med. 2014; 371: 119-129
        • Fauser B.C.
        Reproductive endocrinology: revisiting ovulation induction in PCOS.
        Nat Rev Endocrinol. 2014; 12: 704-705
        • Moons K.G.
        • Altman D.G.
        • Reitsma J.B.
        • Ioannidis J.P.
        • Macaskill P.
        • Steyerberg E.W.
        • et al.
        Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.
        Ann Intern Med. 2015; 162: W1-W73
        • Twomey J.D.
        • Brahme N.N.
        • Zhang B.
        Drug-biomarker co-development in oncology—20 years and counting.
        Drug Resist Updat. 2017; 30: 48-62
        • Hunault C.C.
        • Laven J.S.
        • van Rooij I.A.
        • Eijkemans M.J.
        • te Velde E.R.
        • Habbema J.D.
        Prospective validation of two models predicting pregnancy leading to live birth among untreated subfertile couples.
        Hum Reprod. 2005; 20: 1636-1641
        • Habbema J.D.
        • Eijkemans M.J.
        • Leridon H.
        • te Velde E.R.
        Realizing a desired family size: when should couples start?.
        Hum Reprod. 2015; 30: 2215-2221
        • Koot Y.E.
        • van Hooff S.R.
        • Boomsma C.M.
        • van Leenen D.
        • Groot Koerkamp M.J.
        • Goddijn M.
        • et al.
        An endometrial gene expression signature accurately predicts recurrent implantation failure after IVF.
        Sci Rep. 2016; 6: 19411
        • Haahr T.
        • Jensen J.S.
        • Thomsen L.
        • Duus L.
        • Rygaard K.
        • Humaidan P.
        Abnormal vaginal microbiota may be associated with poor reproductive outcomes: a prospective study in IVF patients.
        Hum Reprod. 2016; 31: 795-803
        • Macklon N.S.
        • Stouffer R.L.
        • Giudice L.C.
        • Fauser B.C.
        The science behind 25 years of ovarian stimulation for in vitro fertilization.
        Endocr Rev. 2006; 27: 170-207
        • Fauser B.C.
        • Diedrich K.
        • Devroey P.
        • Evian Annual Reproduction Workshop Group 2007
        Predictors of ovarian response: progress toward individualized treatment in ovulation induction and ovarian stimulation.
        Hum Reprod Update. 2008; 14: 1-14
        • Imani B.
        • Eijkemans M.J.
        • te Velde E.R.
        • Habbema J.D.
        • Fauser B.C.
        Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.
        J Clin Endocrinol Metab. 1998; 83: 2361-2365
        • Imani B.
        • Eijkemans M.J.
        • te Velde E.R.
        • Habbema J.D.
        • Fauser B.C.
        Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.
        J Clin Endocrinol Metab. 1999; 84: 1617-1622
        • Imani B.
        • Eijkemans M.J.
        • te Velde E.R.
        • Habbema J.D.
        • Fauser B.C.
        A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.
        Fertil Steril. 2002; 77: 91-97
        • Rausch M.E.
        • Legro R.S.
        • Barnhart H.X.
        • Schlaff W.D.
        • Carr B.R.
        • Diamond M.P.
        • et al.
        • Reproductive Medicine Network
        Predictors of pregnancy in women with polycystic ovary syndrome.
        J Clin Endocrinol Metab. 2009; 94: 3458-3466
        • Fauser B.C.
        • Eijkemans M.J.
        Predicting pregnancy in women with polycystic ovary syndrome.
        J Clin Endocrinol Metab. 2009; 94: 3183-3184
        • Broekmans F.J.
        • Soules M.R.
        • Fauser B.C.
        Ovarian aging: mechanisms and clinical consequences.
        Endocr Rev. 2009; 30: 465-493
        • la Marca A.
        • Sunkara S.K.
        Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice.
        Hum Reprod Update. 2014; 20: 124-140
        • Broer S.L.
        • Broekmans F.J.
        • Laven J.S.
        • Fauser B.C.
        Anti-müllerian hormone: ovarian reserve testing and its potential clinical implications.
        Hum Reprod Update. 2014; 20: 688-701
        • Broer S.L.
        • van Disseldorp J.
        • Broeze K.A.
        • Dolleman M.
        • Opmeer B.C.
        • Bossuyt P.
        • et al.
        • IMPORT Study Group
        Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach.
        Hum Reprod Update. 2013; 19: 26-36
        • Broer S.L.
        • Dólleman M.
        • van Disseldorp J.
        • Broeze K.A.
        • Opmeer B.C.
        • Bossuyt P.M.
        • et al.
        • IPD-EXPORT Study Group
        Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis.
        Fertil Steril. 2013; 100: 420-429.e7
        • Nargund G.
        • Datta A.
        • Fauser B.C.
        Mild stimulation for in vitro fertilization.
        Fertil Steril. 2017; 108: 558-567
        • Popovic-Todorovi B.
        • Loft A.
        • Bredkjaeer H.E.
        • Bangsbøll S.
        • Nielsen I.K.
        • Nyboe Andersen A.
        A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a “standard” dose of 150 IU/day in “standard” patients undergoing IVF/ICSI treatment.
        Hum Reprod. 2003; 18: 2275-2282
        • van Tilborg T.C.
        • Eijkemans M.J.
        • Laven J.S.
        • Koks C.A.
        • de Bruin J.P.
        • Scheffer G.J.
        • et al.
        The OPTIMIST study: Optimisation of Cost Effectiveness Through Individualised FSH Stimulation Dosages for IVF Treatment. A randomised controlled trial.
        BMC Womens Health. 2012; 12: 29
        • Olivennes F.
        • Trew G.
        • Borini A.
        • Broekmans F.
        • Arriagada P.
        • Warne D.W.
        • et al.
        Randomized, controlled, open-label, noninferiority study of the CONSORT algorithm for individualized dosing of follitropin alfa.
        Reprod Biomed Online. 2015; 30: 248-257
        • Nyboe Andersen A.
        • Nelson S.M.
        • Fauser B.C.
        • García-Velasco J.A.
        • Klein B.M.
        • Arce J.C.
        • ESTHER-1 Study Group
        Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.
        Fertil Steril. 2017; 107: 387-396
        • Allegra A.
        • Marino A.
        • Volpes A.
        • Coffaro F.
        • Scaglione P.
        • Gullo S.
        • et al.
        A randomized controlled trial investigating the use of a predictive nomogram for the selection of the FSH starting dose in IVF/ICSI cycles.
        Reprod Biomed Online. 2017; 34: 429-438